p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons

p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons

p53, initially considered a tumor suppressor, has been the subject of research related to cancer treatment resistance in the last 30 years. The unfavorable response to multimodal therapy and the higher recurrence rate, despite an aggressive approach, make HNSCC a research topic of interest for impro...

Descripció completa

Dades bibliogràfiques
Autors principals: Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Format: Article
Idioma:English
Publicat: MDPI AG 2022-12-01
Col·lecció:Diagnostics
Matèries:
p53
radiosensitivity
radioresistance
radiotherapy
head and neck cancers
HNSCC
Accés en línia:https://www.mdpi.com/2075-4418/12/12/3052

Internet

https://www.mdpi.com/2075-4418/12/12/3052

Ítems similars